Study of Application of Transcutaneous Pulsed Electrical Stimulation Around Eye in Age-related Macular Degeneration
NCT05259371 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2023-09-11
Summary
This study aims to evaluate the safety and efficacy of applying pulse electrical stimulation around eyes of age-related macular patients.
Conditions
- Early to Moderate Dry Age-Related Macular Degeneration
Interventions
- DRUG
-
Transcutaneous Pulsed Electrical Stimulation (Device: Nu Eyne M02)
Pulse Electrical Stimulation Patients wear our clinical trial device 30mins once a day for 16weeks.
Sponsors & Collaborators
-
Nu Eyne Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-05
- Primary Completion
- 2024-06-30
- Completion
- 2024-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
Toronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular Degeneration
NCT00940407 ·Status: COMPLETED ·Phase: PHASE2
-
BioCurrent Electrical Stimulation for the Treatment of Dry ARMD
NCT02699216 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Fu's Subcutaneous Needling for Age-related Macular Degeneration
NCT07121127 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Microcurrent Stimulation for Dry Age-related Macular Degeneration
NCT04511936 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa
NCT06242379 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
NCT06662162 ·Status: RECRUITING ·Phase: NA
-
Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration
NCT02127463 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intravitreal Bone Marrow-Derived Stem Cells in Patients With Macular Degeneration
NCT01518127 ·Status: COMPLETED ·Phase: NA
-
Evaluation the Pharmacokinetics,Safety,Tolerability of Single Intravitreal Injection RC28-E in Subjects With Wet Age-Related Macular Degeneration
NCT03777254 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Use of Autologous Bone Marrow Derived Stem Cell in Treatment of Age Related Macular Degeneration
NCT02016508 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Photobiomodulation in Dry Age Related Macular Degeneration
NCT06046118 ·Status: RECRUITING ·Phase: NA
-
Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
NCT00100087 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration
NCT01922128 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa
NCT00447980 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)
NCT01625559 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration
NCT05953012 ·Status: COMPLETED ·Phase: PHASE1
-
NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration
NCT05984927 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa
NCT02280135 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
NCT04339764 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration
NCT03372746 ·Status: COMPLETED
-
RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration
NCT04895293 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase II/III Study of Anti-VEGF in Neovascular AMD
NCT00021736 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Safety Study of CNTO 2476 in Patients With Age-Related Macular Degeneration
NCT01226628 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT02087085 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration
NCT02725762 ·Status: COMPLETED ·Phase: NA